查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1639368

实验室化学品 -市场占有率分析、产业趋势/统计、成长预测 (2025-2030)

Laboratory Chemicals - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

实验室化学品市场规模预计到 2025 年为 288.7 亿美元，预计到 2030 年将达到 356.3 亿美元，预测期内（2025-2030 年）复合年增长率为 4.3%。

实验室化学品-市场-IMG1

COVID-19的爆发对2020年的市场产生了负面影响。然而，市场已达到疫情前的水平，预计在预测期内将稳定成长。

主要亮点

  • 实验室化学品市场受到生物和化学科学领域研发活动活性化以及污水处理用途增加的推动。
  • 然而，实验室化学品替代品的可用性可能会阻碍市场成长。
  • 细胞培养、重组 DNA、生物疗法和奈米材料开发等技术的进步预计将在未来提供市场机会。
  • 由于研发活动的活性化，预计欧洲将主导市场。

实验室化学品市场趋势

工业应用证实了更高的成长潜力

  • 实验室化学品广泛用于各种工业製程，从溴化到许多低温反应。
  • 最常见的实验室化学过程包括酰氯製备、羧基化、离子交换反应、硝化、Suzuki 偶联和 Williamson 醚合成。
  • 这些化学物质对于透过结晶和蒸馏过程生产各种商业产品至关重要。
  • 农业产量的增加正在推动全球市场对硫酸的需求。到 2026 年，最不开发中国家的卡路里供应量预计将达到平均每天 2,450 大卡，其他开发中国家则将达到每天 3,000 大卡以上。预计这将增加全球市场对农产品的需求，进而增加对农业研究的需求，进而推动化学製造中对实验室化学品的需求。
  • 目前，美国拥有全球最大的医疗设备产业。根据美国商务部国际贸易管理局（ITA）的SelectUSA计划，该国的医疗设备医疗设备是全球最大的，价值1,560亿美元，预计到2023年将达到2,080亿美元。
  • 根据美国精算师办公室（CMS）发布的资料，预计医疗保健支出在预测期内将大幅增加。
  • 劳动和工业安全以及事故预防也导致研发部门增加投资，以开发更永续、对环境危害更小的新化学品。
  • 因此，工业部门需求的增加预计将增加对实验室化学品的需求。

预计欧洲将主导市场

  • 多年来，义大利工业发生了巨大变化，更加面向国际市场，竞争力也更强。
  • 义大利拥有世界上最大的化学品市场之一。该国的化学品销售额在欧盟 (EU) 中排名第三，占该地区化学品销售额的 11% 以上。义大利不仅是主要的化学品生产国，也是主要的国际化学品出口国。
  • 义大利主要集中在中高科技领域（医药、机械、工业等）。即使在传统领域，义大利工业也坚定地致力于创新，专利申请数量的迅速增加就证明了这一点。
  • 近年来，义大利製药业在生产、投资和贸易方面均取得了显着成长。 CDMO（委外研发机构）是义大利製药业的主要结构，透过将生产步骤委託给第三方设施来发挥作用，从而实现产量的高速成长。
  • 德国製药市场被世界领先的製药公司视为一个有前途的子部门，这些公司正在向德国扩张，以巩固其在全球市场的地位。例如
  • 2022 年 8 月，全球製药公司拜耳将投资 2.8698 亿美元在德国勒沃库森开发其 Solida-1 製药厂。该设施预计将于 2024 年运作，将致力于生产癌症和心血管疾病的治疗药物。
  • 爱尔兰是领先的製药中心，占世界药品产量的 5% 以上。爱尔兰製药业多年来的发展以全球最大的九家製药公司的存在为标誌，其中爱尔兰生产了世界十大最畅销药品中的七种。此外，过去十年，製药业也受惠于约 80 亿美元的新设施投资。
  • 义大利拥有 5,000 多家製药公司，其中包括 Menarini、Chiesi、Angelini、Bracco、Recordati 和 Alpha Sigma 等主要企业。为了因应市场需求的逐步持续成长，这些企业在过去的十年中一直保持着产值的持续成长。
  • 义大利製造业在税收优惠的支持下，已开始维修各种生产工厂，特别是工业4.0技术方面。
  • 预计此类发展将增加预测期内对实验室化学品的需求。

实验室化学品行业概况

据估计，实验室化学品市场将部分分为全球参与企业和本地参与者。实验室化学品市场公认的主要企业包括（排名不分先后）ITW Reagents Division、Merck KGaA、Beckman Coulter Inc.、General Electric 和 Avantor Inc.。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 3 个月分析师支持

目录

第一章简介

  • 调查先决条件
  • 调查范围

第二章调查方法

第三章执行摘要

第四章市场动态

  • 促进因素
    • 扩大生化领域的研发活动
    • 增加污水处理中的使用
    • 其他司机
  • 抑制因素
    • 实验室化学品替代品的可用性
    • 其他限制因素
  • 产业价值链分析
  • 波特五力分析
    • 供应商的议价能力
    • 消费者议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争程度

第五章市场区隔（以金额为准的市场规模）

  • 类型
    • 分子生物学
    • 细胞激素/趋化素测试
    • 聚醣分析
    • 免疫化学
    • 细胞/组织培养
    • 环保检验
    • 生物化学
    • 其他的
  • 目的
    • 工业的
    • 学术/教育
    • 政府机构
    • 医疗（製药）
  • 地区
    • 亚太地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 其他亚太地区
    • 北美洲
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 义大利
      • 法国
      • 西班牙
      • 欧洲其他地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 南美洲其他地区
    • 中东/非洲
      • 沙乌地阿拉伯
      • 南非
      • 其他中东/非洲

第六章 竞争状况

  • 併购、合资、联盟、协议
  • 市场占有率(%)**/排名分析
  • 主要企业策略
  • 公司简介
    • Avantor Inc.
    • BD BioScience
    • Beckman Coulter Inc.
    • BiosYnth SRL
    • Carlo Erba Reagents SRL
    • GE Healthcare
    • ITW Reagents Division
    • Merck KGaA
    • Meridian Life Science Inc.
    • Mitsubishi Rayon Co. Ltd
    • Morphisto GmbH
    • PerkinElmer Inc.
    • R&D Systems
    • Sigma-Aldrich Corp.
    • UJIFILM Wako Chemicals

第七章 市场机会及未来趋势

  • 细胞培养、重组 DNA 和生物治疗等技术的进步
  • 活性化奈米材料开发研究活动
简介目录
Product Code: 48894

The Laboratory Chemicals Market size is estimated at USD 28.87 billion in 2025, and is expected to reach USD 35.63 billion by 2030, at a CAGR of 4.3% during the forecast period (2025-2030).

Laboratory Chemicals - Market - IMG1

The COVID-19 outbreak negatively impacted the market in 2020. However, the market has since reached pre-pandemic levels and is expected to grow steadily during the forecast period.

Key Highlights

  • The laboratory chemicals market is driven by growing R&D activities in the field of biological and chemical sciences and increasing usage in wastewater treatment.
  • However, the availability of substitutes for laboratory chemicals is likely to hinder the market's growth.
  • Advancements in technologies, such as cell culture, recombinant DNA, and biotherapeutics, and the development of nanomaterials are projected to act as an opportunity for the market in the future.
  • Due to increasing research and development activities, Europe region is expected to dominate the market.

Laboratory Chemicals Market Trends

Industrial Application to Witness the Higher Potential Growth

  • Laboratory chemicals are extensively used in various industrial processes, ranging from bromination to numerous cryogenic reactions.
  • Some of the most common laboratory chemical processes include acid chloride preparations, carboxylation, ion-exchange reactions, nitration, Suzuki coupling, and Williamson's ether synthesis.
  • These chemicals are essential to manufacture various commercial products in re-crystallization and distillation processes.
  • Increasing agricultural output is boosting the demand for sulphuric acid in the global market. By 2026, calorie availability is projected to reach 2,450 kcal on average in least-developed countries and exceed 3,000 kcal per day in other developing countries. This is expected to increase the demand for crops in the global market, which, in turn, may increase the demand for agricultural research, thus, driving up the need for laboratory chemicals in chemical manufacturing.
  • Currently, the United States is the largest medical device industry in the world. According to SelectUSA, a program by The International Trade Administration (ITA), US Department of Commerce, the medical devices market in the country is the largest medical devices market in the world, which is valued at USD 156 billion and is estimated to reach USD 208 billion by 2023.
  • As per data published by the United States; CMS (Office of the Actuary), healthcare expenditure is expected to increase significantly during the forecast period.
  • Occupational and industrial safety and disaster prevention have led to increasing investments in the R&D department to formulate new chemicals that are equally sustainable and less hazardous to the environment.
  • Hence, growing demand from the industrial sector is expected to increase the demand for laboratory chemicals.

Europe Region is Expected to Dominate the Market

  • The Italian industry has changed significantly over the years, orienting itself toward international markets and strengthening its competitiveness.
  • Italy has one of the world's largest chemical marketplaces. The country has the third-largest chemical revenue in the European Union, accounting for above 11% of regional chemical sales. Aside from being a major chemical producer, Italy is also a major chemical exporter internationally.
  • Its focus has been mainly on medium to high-technology sectors (such as pharmaceuticals, mechanics, and the chemical industry). Even in the traditional sectors, the Italian industry focused on strong innovation, as evidenced by the sharp increase in patent applications.
  • The Italian pharmaceutical industry has grown considerably in production, investments, and trade over recent years. CDMO (Contract Development Manufacturing Organization) is the main structure of the Italian pharmaceutical industry, which functions by outsourcing production stages to third-party facilities, thereby enabling high production growth.
  • The pharmaceutical market in Germany is identified as a top-prospect sub-sector by world-leading pharmaceutical manufacturing companies, which are expanding into the country to strengthen their position in the global market. For instance,
  • In August 2022, the critical global pharmaceutical player, Bayer, is undergoing the development of the Solida-1 pharmaceutical production facility at its site in Leverkusen in, Germany, for an investment of USD 286.98 million. The facility, which is expected to come on stream in 2024, shall be dedicated to producing drugs for treating cancer and cardiovascular diseases.
  • Ireland is a prominent pharmaceutical location contributing to more than 5% of global pharmaceutical production. The growth in Ireland's pharmaceutical sector over the years is marked by the presence of 9 of the world's largest pharmaceutical companies, enabling the country to produce 7 of the top 10 selling drugs globally. Further, the sector has benefitted from around USD 8 billion investment in setting up new facilities over the 10 years.
  • Italy boasts over 5,000 pharmaceutical companies, with top players including Menarini, Chiesi, Angelini, Bracco, Recordati, and Alfasigma, among others. Responding to the gradual and continuous rise in market demand, these companies have maintained continued growth in production value through the last decade.
  • The Italian manufacturing sector has started renovating various production plants, particularly concerning Industry 4.0 technologies, supported by tax incentives.
  • All such developments are expected to boost the demand for laboratory chemicals during the forecast period.

Laboratory Chemicals Industry Overview

The laboratory chemicals market is estimated to be partially fragmented, with the presence of global and local players. Major recognized players in the laboratory chemicals market (not in any particular order) include ITW Reagents Division, Merck KGaA, Beckman Coulter Inc., General Electric, and Avantor Inc.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Drivers
    • 4.1.1 Growing R&D Activities in the Field of Biological and Chemical Sciences
    • 4.1.2 Increasing Usage in Wastewater Treatment
    • 4.1.3 Other Drivers
  • 4.2 Restraints
    • 4.2.1 Availability of Substitutes for Laboratory Chemicals
    • 4.2.2 Other Restraints
  • 4.3 Industry Value Chain Analysis
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Degree of Competition

5 MARKET SEGMENTATION (Market Size in Value)

  • 5.1 Type
    • 5.1.1 Molecular Biology
    • 5.1.2 Cytokine and Chemokine Testing
    • 5.1.3 Carbohydrate Analysis
    • 5.1.4 Immunochemistry
    • 5.1.5 Cell/Tissue Culture
    • 5.1.6 Environmental Testing
    • 5.1.7 Biochemistry
    • 5.1.8 Other Types
  • 5.2 Application
    • 5.2.1 Industrial
    • 5.2.2 Academia/Educational
    • 5.2.3 Government
    • 5.2.4 Healthcare (Pharmaceutical)
  • 5.3 Geography
    • 5.3.1 Asia-Pacific
      • 5.3.1.1 China
      • 5.3.1.2 India
      • 5.3.1.3 Japan
      • 5.3.1.4 South Korea
      • 5.3.1.5 Rest of Asia-Pacific
    • 5.3.2 North America
      • 5.3.2.1 United States
      • 5.3.2.2 Canada
      • 5.3.2.3 Mexico
    • 5.3.3 Europe
      • 5.3.3.1 Germany
      • 5.3.3.2 United Kingdom
      • 5.3.3.3 Italy
      • 5.3.3.4 France
      • 5.3.3.5 Spain
      • 5.3.3.6 Rest of Europe
    • 5.3.4 South America
      • 5.3.4.1 Brazil
      • 5.3.4.2 Argentina
      • 5.3.4.3 Rest of South America
    • 5.3.5 Middle-East and Africa
      • 5.3.5.1 Saudi Arabia
      • 5.3.5.2 South Africa
      • 5.3.5.3 Rest of Middle-East and Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements
  • 6.2 Market Share(%)**/Ranking Analysis
  • 6.3 Strategies Adopted by Leading Players
  • 6.4 Company Profiles
    • 6.4.1 Avantor Inc.
    • 6.4.2 BD BioScience
    • 6.4.3 Beckman Coulter Inc.
    • 6.4.4 BiosYnth SRL
    • 6.4.5 Carlo Erba Reagents SRL
    • 6.4.6 GE Healthcare
    • 6.4.7 ITW Reagents Division
    • 6.4.8 Merck KGaA
    • 6.4.9 Meridian Life Science Inc.
    • 6.4.10 Mitsubishi Rayon Co. Ltd
    • 6.4.11 Morphisto GmbH
    • 6.4.12 PerkinElmer Inc.
    • 6.4.13 R&D Systems
    • 6.4.14 Sigma-Aldrich Corp.
    • 6.4.15 UJIFILM Wako Chemicals

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

  • 7.1 Advancement in Technologies, such as Cell Culture, Recombinant DNA, and Biotherapeutics
  • 7.2 Increasing Research Activities for Development of Nanomaterials